Literature DB >> 10366747

Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors.

T Nishizaki1, T Nomura, T Matsuoka, G Enikolopov, K Sumikawa.   

Abstract

The present study was conducted to understand the effect of arachidonic acid on nicotinic acetylcholine (ACh) receptor-mediated synaptic plasticity. Arachidonic acid persistently (>/=1 h) potentiated currents through neuronal nicotinic ACh receptors (alpha7 and alpha4beta2) expressed in Xenopus oocytes, and the effect was blocked by the selective protein kinase C (PKC) inhibitors, such as GF109203X, PKCI, and co-expressed active PKC inhibitor peptide. This free fatty acid markedly increased nicotine-sensitive glutamate release from hippocampal slices and enhanced the rate of nicotine-sensitive miniature excitatory postsynaptic currents without affecting the amplitude in cultured hippocampal CA1 neurons under the influence of PKC. Furthermore, arachidonic acid induced a long-lasting (>/=3 h) facilitation of hippocampal CA1 synaptic transmission in slices, and the effect was blocked by nicotinic ACh receptor antagonists, alpha-bungarotoxin and mecamylamine. The facilitation, whereas independent of N-methyl-D-aspartate (NMDA) receptors, shares a common mechanism with long-term potentiation (LTP) induced by tetanic stimulation. The results of the present study thus suggest that arachidonic acid sustains enhanced activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to an 'LTP-like' facilitation of hippocampal synaptic transmission. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366747     DOI: 10.1016/s0169-328x(99)00117-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  14 in total

Review 1.  Deconstructing memory in Drosophila.

Authors:  Carla Margulies; Tim Tully; Josh Dubnau
Journal:  Curr Biol       Date:  2005-09-06       Impact factor: 10.834

2.  Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.

Authors:  Irene Morganstern; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Jane Shaji; Olga Karatayev; Sarah F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

3.  Free fatty acid derivative HUHS2002 potentiates α7 ACh receptor responses through indirect activation of CaMKII.

Authors:  Takeshi Kanno; Tadashi Shimizu; Akito Tanaka; Takaaki Nishimoto; Tomoyuki Nishizaki
Journal:  Lipids       Date:  2012-07-21       Impact factor: 1.880

4.  Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption.

Authors:  Irene Morganstern; Zhiy Ye; Sherry Liang; Shawn Fagan; Sarah F Leibowitz
Journal:  Brain Res       Date:  2012-07-02       Impact factor: 3.252

5.  Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.

Authors:  R Fabian-Fine; P Skehel; M L Errington; H A Davies; E Sher; M G Stewart; A Fine
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine ameliorates age-related spatial memory deterioration by preventing neuronal cell death.

Authors:  Takahiro Yaguchi; Tetsu Nagata; Tomoyuki Nishizaki
Journal:  Behav Brain Funct       Date:  2010-09-13       Impact factor: 3.759

Review 8.  Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.

Authors:  Angelo O Rosa; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2009-03-25

9.  Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure.

Authors:  Pınar Kanlikilicer; Die Zhang; Andrei Dragomir; Yasemin M Akay; Metin Akay
Journal:  Med Biol Eng Comput       Date:  2016-06-02       Impact factor: 2.602

Review 10.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.